Cardiology

Top Story

Leadless pacemakers linked with fewer overall complications vs. transvenous pacemakers

Leadless pacemakers linked with fewer overall complications vs. transvenous pacemakers
May 24, 2016

SAN FRANCISCO — Patients requiring single-chamber pacing experience fewer overall complications with a leadless pacemaker than with a transvenous pacemaker, according to data presented at the Heart Rhythm Society Annual Scientific Sessions.

Vivek Y. Red dy, MD , and colleagues compared acute and midterm adverse event rates of leadless pacemakers (Nanostim, St. Jude Medical) vs. transvenous pacemakers. Using data from the LEADLESS II clinical trial and Truven Health MarketScan databases, 718 patients with a leadless pacemaker and 10,521 patients with a transvenous pacemaker were included in the study. Mean follow-up was 10 months.

In the Journals

One-year prognosis suboptimal after reintervention for in-stent restenosis

May 24, 2016
Patients who developed in-stent restenosis after implantation of a drug-eluting stent to treat femoropopliteal lesions had high rates of recurrent stenosis after…
Meeting News Coverage

Patients with familial chylomicronemia syndrome at high risk for acute pancreatitis

May 24, 2016
NEW ORLEANS — Patients with familial chylomicronemia syndrome, a rare lipid disorder, have an increased risk for acute pancreatitis, researchers reported at the…
Meeting News Coverage

PCSK9 inhibitors benefit patients with residual LDL burden

May 24, 2016
NEW ORLEANS — A leading authority on PCSK9 inhibitors told the audience at the National Lipid Association Scientific Sessions that while the drugs can lower LDL by…
Meeting News Coverage

Top Takeaways from ASH: Oral anticoagulants shift cancer-related thrombosis treatment paradigm

May 24, 2016
With a range of questions lingering unanswered in the arena of cancer-related thrombosis, new research presented at the ASH Annual Meeting and Exposition armed…
More News Headlines »
morganatic-roan
morganatic-roan